Tecnovatica S.A. (WSE:TEC)

Market Cap	5.91M +31.0%
Revenue (ttm)	125.86K
Net Income	-87.83K
EPS	-0.01
Shares Out	10.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50
Open	0.5500
Previous Close	0.5520
Day's Range	0.5500 - 0.5500
52-Week Range	0.2280 - 0.8560
Beta	0.43
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Tecnovatica

Tecnovatica S.A. does not have significant operations. Previously, it engaged in the building and development of an integrated ecosystem of health services using modern genetics and imaging diagnostics in Poland, the European Union and global markets. The company was formerly known as Vinci Gen S.A. and changed its name to Tecnovatica S.A. in January 2026. Tecnovatica S.A. was founded in 2010 and is headquartered in Koszalin, Poland.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2010
• Employees: 1
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: TEC

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 26, 2026

Data Sources Report a data error